Dr. Bahri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2023 - 2026
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2014 - 2017
- Commonwealth Medical CollegeClass of 2014
- Georgetown University MS, 2008 - 2009
- New York University BA, 2004 - 2008
Certifications & Licensure
- CA State Medical License 2017 - 2025
- NY State Medical License 2016 - 2018
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 21 citationsMaking clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.Joaquin Martinez-Lopez, Rafael Feito Alonso, Sandy W. Wong, Rafael Rios, Nina Shah
Journal of Hematology & Oncology. 2021-08-17 - 18 citationsThe clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.Maria-Teresa Cedena, Estela Martín-Clavero, Sandy W. Wong, Nina Shah, Natasha Bahri
Plos One. 2020-08-31 - 22 citationsClinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.Joaquin Martinez-Lopez, Sandy W. Wong, Nina Shah, Natasha Bahri, Kaili Zhou
Blood Advances. 2020-07-28
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: